Login to Your Account

U.S. Patent Disclosures

Wednesday, June 6, 2012
• Durect Corp., of Cupertino, Calif., and Pain Therapeutics Inc., of Austin, Texas, were issued four patents relating to their Oradur technology, Remoxy (oxycodone) Extended-Release Capsules CII and other Oradur-based opioids.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription